Symbols / LBRX Stock $31.78 +0.00% LB Pharmaceuticals Inc

Healthcare • Biotechnology • United States • NGM
LBRX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 911.29M Enterprise Value 619.64M Income -25.20M Sales — Book/sh 11.91 Cash/sh 10.29
Dividend Yield — Payout 0.00% Employees 27 IPO — P/E — Forward P/E -7.44
PEG — P/S — P/B 2.67 P/C — EV/EBITDA -21.23 EV/Sales —
Quick Ratio 39.67 Current Ratio 41.45 Debt/Eq 1.18 LT Debt/Eq — EPS (ttm) -3.13 EPS next Y -4.27
EPS Growth — Revenue Growth — Earnings 2026-05-15 ROA -10.65% ROE -15.70% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 28.67M Shs Float 19.71M Short Float 9.63%
Short Ratio 10.43 Short Interest — 52W High 32.91 52W Low 13.36 Beta — Avg Volume 255.86K
Volume 251.13K Target Price $43.80 Recom Strong_buy Prev Close $31.78 Price $31.78 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-17.09
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest LBRX news

No recent news from Yahoo. Try the RSS feed for latest LBRX news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-12 NUSSBAUM RAN Director — 1,000,000 $15.00 $15,000,000
2025-09-12 NUSSBAUM RAN Director — 411,681 — —
2025-09-12 PONTIFAX MANAGEMENT 4 G.P. 2015, LTD. Beneficial Owner of more than 10% of a Class of Security — 1,000,000 $15.00 $15,000,000
2025-09-12 PONTIFAX MANAGEMENT 4 G.P. 2015, LTD. Beneficial Owner of more than 10% of a Class of Security — 411,681 — —
2025-09-12 VIDA VENTURES GP III, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 333,333 $15.00 $4,999,995
2025-09-12 VIDA VENTURES GP III, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 548,910 — —
2025-09-12 DEEP TRACK BIOTECHNOLOGY MASTER FUND LTD Beneficial Owner of more than 10% of a Class of Security — 2,666,666 $15.00 $39,999,990
2025-09-12 DEEP TRACK BIOTECHNOLOGY MASTER FUND LTD Beneficial Owner of more than 10% of a Class of Security — 686,138 — —
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category